• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国肝细胞癌肝移植中的种族差异:最新进展。

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.

机构信息

Department of Medicine, Lincoln Medical Center/Weill Cornell Medicine, New York, NY, USA.

Department of Medicine, SIU School of Medicine, Springfield, IL, USA.

出版信息

Dig Dis Sci. 2023 Oct;68(10):4050-4059. doi: 10.1007/s10620-023-08084-z. Epub 2023 Aug 16.

DOI:10.1007/s10620-023-08084-z
PMID:37584869
Abstract

BACKGROUND

Previous studies have demonstrated a disparity in liver transplantation (LT) for hepatocellular carcinoma (HCC) among races in the United States (U.S.).

AIMS

We aimed to update the literature on the odds, trends, and complications of LT in the treatment of hepatocellular carcinoma (HCC), among individuals of different racial backgrounds.

METHODS

This is a nationwide study of adult individuals admitted for LT with a primary diagnosis of HCC. Using weighted data from the National Inpatient Sample (NIS) database, we compared the odds of LT among different races from 2016 to 2020, using a multivariate regression analysis. We further assessed the trends and outcomes of LT among races.

RESULTS

A total of 112,110 adult were hospitalized with a primary diagnosis of HCC. 3020 underwent LT. When compared to Whites, the likelihood of undergoing LT for HCC was significantly reduced in Blacks (OR = 0.60, 95% CI = 0.46-0.78). Further, Blacks had increased mortality rates (7% in Blacks vs. 1% in Whites, p < 0.001), sepsis (11% in Blacks vs. 3% in Whites, p = 0.015), and acute kidney injury (AKI) (54% in Blacks vs. 31% in Whites, p < 0.001) following LT.

CONCLUSIONS

Individuals identifying as Blacks were less likely to undergo LT for HCC, and more likely to develop complications. Further initiatives are warranted to mitigate the existing disparities among racial groups.

摘要

背景

先前的研究表明,在美国(U.S.)不同种族之间,肝移植(LT)治疗肝细胞癌(HCC)的比例存在差异。

目的

我们旨在更新有关不同种族背景个体接受 LT 治疗 HCC 的几率、趋势和并发症的文献。

方法

这是一项针对因 HCC 接受 LT 的成年个体的全国性研究。我们使用国家住院患者样本(NIS)数据库的加权数据,通过多变量回归分析,比较了 2016 年至 2020 年不同种族之间接受 LT 的几率。我们进一步评估了不同种族之间 LT 的趋势和结果。

结果

共有 112110 名成年个体因 HCC 接受住院治疗。其中 3020 人接受了 LT。与白人相比,黑人接受 HCC 接受 LT 的几率明显降低(OR=0.60,95%CI=0.46-0.78)。此外,黑人的死亡率更高(黑人 7%,白人 1%,p<0.001),败血症(黑人 11%,白人 3%,p=0.015)和急性肾损伤(AKI)(黑人 54%,白人 31%,p<0.001)的发病率也更高。

结论

自认为是黑人的个体接受 HCC 接受 LT 的可能性较小,发生并发症的可能性更大。需要进一步采取措施来减少不同种族群体之间的现有差距。

相似文献

1
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.美国肝细胞癌肝移植中的种族差异:最新进展。
Dig Dis Sci. 2023 Oct;68(10):4050-4059. doi: 10.1007/s10620-023-08084-z. Epub 2023 Aug 16.
2
Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States.美国肝细胞癌住院治疗结局的种族差异。
Mayo Clin Proc. 2016 Sep;91(9):1173-82. doi: 10.1016/j.mayocp.2016.06.009. Epub 2016 Aug 3.
3
Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.肝细胞癌诊断分期中种族/族裔特异性差异及其对根治性治疗接受情况的影响
J Clin Gastroenterol. 2016 May-Jun;50(5):423-30. doi: 10.1097/MCG.0000000000000448.
4
Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.近期肝细胞癌患者的种族差异与肝移植率:监测、流行病学和最终结果登记处的结果
Liver Transpl. 2014 May;20(5):528-35. doi: 10.1002/lt.23820. Epub 2014 Feb 25.
5
Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.1998 年至 2007 年期间,美国肝癌患者接受肝移植治疗的持续性差异。
Cancer. 2011 Oct 1;117(19):4531-9. doi: 10.1002/cncr.26063. Epub 2011 Mar 29.
6
Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma.种族、民族和社会经济差异影响肝癌患者肝移植后的生存。
Ann Hepatol. 2023 Sep-Oct;28(5):101127. doi: 10.1016/j.aohep.2023.101127. Epub 2023 Jun 5.
7
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma: Analysis of the National Inpatient Sample From 2007 to 2014.种族差异在肝细胞癌肝移植中的表现:2007 年至 2014 年全国住院患者样本分析。
J Clin Gastroenterol. 2023 Mar 1;57(3):311-316. doi: 10.1097/MCG.0000000000001675.
8
The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.种族对美国多样化人群肝癌生存的影响。
Dig Dis Sci. 2018 Feb;63(2):515-528. doi: 10.1007/s10620-017-4869-3. Epub 2017 Dec 23.
9
Recent Improvements in Racial Disparity in the Treatment of Hepatocellular Carcinoma: How Times Have Changed.近年来肝癌治疗中种族差异的改善:时代的变迁。
J Gastrointest Surg. 2021 Oct;25(10):2535-2544. doi: 10.1007/s11605-021-04912-7. Epub 2021 Feb 5.
10
Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.比较公共医疗保险与私人医疗保险患者的肝癌肝移植候补名单结果。
JAMA Netw Open. 2019 Aug 2;2(8):e1910326. doi: 10.1001/jamanetworkopen.2019.10326.

引用本文的文献

1
Liver Transplantation for Cancer-Current Challenges and Emerging Solutions.癌症的肝移植——当前挑战与新出现的解决办法
J Clin Med. 2025 Jul 29;14(15):5365. doi: 10.3390/jcm14155365.
2
Racial and Ethnic Differences in Liver Transplantation and Post-Liver Transplant Survival Among Patients With Hepatocellular Carcinoma.种族和民族差异对肝癌患者肝移植和肝移植后生存的影响。
Cancer Med. 2024 Nov;13(21):e70298. doi: 10.1002/cam4.70298.
3
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma.丙型肝炎相关肝细胞癌肝移植中的种族差异

本文引用的文献

1
Short-Term Outcomes Following Left Atrial Appendage Closure in the Very Elderly: A Population-Based Analysis.高龄患者行左心耳封堵术后的短期结局:基于人群的分析。
J Am Heart Assoc. 2022 Aug 16;11(16):e024574. doi: 10.1161/JAHA.121.024574. Epub 2022 Aug 5.
2
Multicenter study of racial and ethnic inequities in liver transplantation evaluation: Understanding mechanisms and identifying solutions.多中心研究种族和民族在肝移植评估中的不平等:了解机制和确定解决方案。
Liver Transpl. 2022 Dec;28(12):1841-1856. doi: 10.1002/lt.26532. Epub 2022 Jul 28.
3
Liver Transplantation Criteria for Hepatocellular Carcinoma, Including Posttransplant Management.
Ann Surg Oncol. 2025 Jan;32(1):426-437. doi: 10.1245/s10434-024-16317-2. Epub 2024 Oct 16.
肝细胞癌的肝移植标准,包括移植后管理。
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):332-336. doi: 10.1002/cld.1054. eCollection 2021 May.
4
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.肝移植患者 COVID-19 的流行病学模式、发病率和结局。
J Hepatol. 2021 Jan;74(1):148-155. doi: 10.1016/j.jhep.2020.07.040. Epub 2020 Aug 1.
5
In-hospital outcomes of percutaneous mitral valve repair in patients with chronic obstructive pulmonary disease: insights from the national inpatient sample database.慢性阻塞性肺疾病患者经皮二尖瓣修复术的院内转归:来自全国住院患者样本数据库的见解。
Catheter Cardiovasc Interv. 2021 Jan 1;97(1):E104-E112. doi: 10.1002/ccd.28913. Epub 2020 May 6.
6
Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.美国住院成年人群慢性肝脏疾病负担的变化趋势。
JAMA Netw Open. 2020 Apr 1;3(4):e201997. doi: 10.1001/jamanetworkopen.2020.1997.
7
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.肝移植治疗肝细胞癌。ILTS 移植肿瘤学共识会议工作组报告。
Transplantation. 2020 Jun;104(6):1136-1142. doi: 10.1097/TP.0000000000003174.
8
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden.肝细胞癌肝移植中的种族差异无法用合并症、肝病严重程度或肿瘤负荷的差异来解释。
Hepatol Commun. 2018 Dec 3;3(1):52-62. doi: 10.1002/hep4.1277. eCollection 2019 Jan.
9
Increasing Awareness on Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States.美国对肝细胞癌肝移植中种族差异的认识不断提高。
Hepatol Commun. 2019 Jan 1;3(1):5-7. doi: 10.1002/hep4.1299. eCollection 2019 Jan.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.